SPH Notice – Allianz SE

1
Internal
Disclosure of ceasing to have substantial holding
Section 279, Financial Markets Conduct Act 2013
To NZX Limited
and
To EROAD Limited
Date this disclosure made: 2 December 2021
Date last disclosure made: 2 August 2021
Date on which substantial holding ceased: 30 November 2021
Substantial product holder(s) giving disclosure
Full name(s):
Allianz SE as ultimate parent company

Allianz Global Investors Asia Pacific Ltd. (investment
discretion)
Allianz Global Investors GmbH (parent company)
Allianz Asset Management GmbH (parent company)

Allianz Global Investors U.S. LLC (investment discretion)
Allianz Global Investors U.S. Holdings LLC (parent company)
PFP Holdings Inc. (parent company)
Allianz of America Inc. (parent company)
Allianz Europe B.V. (parent company)

Summary of previous substantial holding
Class of quoted voting products: Ordinary share
For last disclosure,—
Substantial product holder
(a) Total number
held in class
(b) Total in
class
(c) Total
percentage
held in class

Allianz Global Investors Asia
Pacific Ltd.
4.854.167 81.896.340 5,93%

Allianz Global Investors U.S. LLC 116.947 81.896.340 0,14%

Total (sum)

4.971.114

81.896.340

6,07%


For current holding after ceasing to have substantial holding,—
Substantial product holder
(a) Total number
held in class
(b) Total in
class
(c) Total
percentage
held in class

2
Internal
Allianz Global Investors Asia
Pacific Ltd.
5.371.667

110.338.787 4,87%

Allianz Global Investors U.S. LLC 119.747


110.338.787

0,11%

Total (sum)

5.491.414


110.338.787

4,98%



Details of transactions and events giving rise to ceasing of substantial holding
Details of the transactions or other events requiring disclosure:
Registered
holder
Date of
transaction
Nature of
the
transaction
ISIN Price per share Number of securities
Commission de
la Caisse
Commune
AllianzGI SC Asia 02.08.2021 Buy



NZERDE0001S5
6,3321 61.800
Commission de
la Caisse
Commune
AllianzGI SC Asia 25.08.2021 Buy



NZERDE0001S5
6,0392 27.099
Commission de
la Caisse
Commune
AllianzGI SC Asia 25.08.2021 Buy



NZERDE0001S5
5,9997 5.101
Virtus AllianzGI
International
Small-Cap Fund 27.09.2021 Sell


NZERDE0001S5
5,5745 -9.700
AllianzGI-Fonds
RANW II
Segment RANW
Oriental Income 12.10.2021 Sell



NZERDE0001S5
5,1909 -27.187
Allianz Choice
Oriental Fund 12.10.2021 Sell

NZERDE0001S5
5,1909 -3.795
Allianz Choice
Oriental Fund 13.10.2021 Sell

NZERDE0001S5
5,1324 -4.400
AllianzGI-Fonds
RANW II
Segment RANW
Oriental Income 13.10.2021 Sell



NZERDE0001S5
5,1324 -31.524
Allianz Choice
Oriental Fund 14.10.2021 Sell

NZERDE0001S5
5,1626 -4.177
AllianzGI-Fonds
RANW II
Segment RANW
Oriental Income 14.10.2021 Sell



NZERDE0001S5
5,1626 -29.927
AllianzGI-Fonds
RANW II
Segment RANW
Oriental Income 15.10.2021 Sell



NZERDE0001S5
5,2303 -24.562

3
Internal
Allianz Choice
Oriental Fund 15.10.2021 Sell

NZERDE0001S5
5,2303 -3.428

Additional information
The event for ceasing to have substantial holding is triggered by a capital change as
announced by EROAD Limited on the 1 December 2021.
Address(es) of substantial product holder(s):
Allianz SE
Königinstrasse 28
80802 Munich, Germany

Contact details:
Michael Sieburg
+49 89 3800 19957
michael.sieburg@allianz.com

*Nature of connection between substantial product holders:
Allianz Global Investors Asia Pacific Ltd. is a direct subsidiary of Allianz Global Investors GmbH
Allianz Global Investors GmbH is a direct subsidiary of Allianz Asset Management GmbH
Allianz Asset Management GmbH is a direct subsidiary of Allianz SE

Allianz Global Investors U.S. LLC is a direct subsidiary of Allianz Global Investors U.S. Holdings LLC
Allianz Global Investors U.S. Holdings LLC is a direct subsidiary of PFP Holdings Inc.
PFP Holdings Inc. is a direct subsidiary of Allianz of America Inc.
Allianz of America Inc. is a direct subsidiary of Allianz Europe B.V.
Allianz Europe B.V. is a direct subsidiary of Allianz SE

Certification
I, Michael Sieburg certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to make this disclosure
by all persons for whom it is made.